Viswa Colluru, Enveda CEO
Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas
Biotech startup Enveda has raised a $130 million Series C, the Colorado company said Thursday morning.
Founded and led by early …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
